Efficacy and Safety of Inhaled Human Insulin (Exubera) Compared With Subcutaneous Human Insulin in the Therapy of Adult Subjects With Type 1 or Type 2 Diabetes Mellitus and Chronic Obstructive Pulmonary Disease: A One-Year, Multicenter, Randomized, Outpatient, Open-Label, Parallel-Group Comparative Trial.
Phase of Trial: Phase III
Latest Information Update: 09 Feb 2010
At a glance
- Drugs Insulin; Insulin
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Pfizer
- 31 Aug 2018 Biomarkers information updated
- 17 Nov 2009 Actual patient number (105) added as reported by ClinicalTrials.gov.
- 28 Oct 2008 Status changed from active, no longer recruiting to discontinued according to Clinicaltrials.gov record.